have been halted due to a possible serious adverse reaction. The company is now investigating whether or not the issue is directly related to the vaccine.
AstraZeneca's COVID-19 vaccine, which is being developed with researchers at Oxford University, is one of just a few candidates that's in Phase 3 trials in the U.S. right now, meaning it is one of those furthest along in the testing process. Previously, the vaccine had been in testing in combined Phase 2 and 3 trials in the U.K. and Brazil as well as a combined Phase 1 and 2 trial in South Africa. But after a trial participant in the U.K.
There aren't a ton of public details about the participant's condition or the timing of their diagnosis, but the
Vi har sammanfattat den här nyheten så att du kan läsa den snabbt. Om du är intresserad av nyheterna kan du läsa hela texten här. Läs mer: